001     875084
005     20210113100813.0
024 7 _ |a 10.1016/j.compchemeng.2020.106851
|2 doi
024 7 _ |a 0098-1354
|2 ISSN
024 7 _ |a 1873-4375
|2 ISSN
024 7 _ |a 2128/24983
|2 Handle
024 7 _ |a WOS:000538049100009
|2 WOS
037 _ _ |a FZJ-2020-01793
082 _ _ |a 660
100 1 _ |a He, Qiao-Le
|0 P:(DE-Juel1)165710
|b 0
245 _ _ |a Model-based process design of a ternary protein separation using multi-step gradient ion-exchange SMB chromatography
260 _ _ |a Amsterdam [u.a.]
|c 2020
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1610473283_22196
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Model-based process design of ion-exchange simulated moving bed (iex-smb) chromatography for center-cut separation of proteins is studied. Use of nonlinear binding models that describe more accurate adsorption behaviors of macro-molecules could make it impossible to utilize triangle theory to obtain operating parameters. Moreover, triangle theory provides no rules to design salt profiles in iex-smb. In the modeling study here, proteins (i.e., ribonuclease, cytochrome and lysozyme) on chromatographic columns packed with strong cation-exchanger SP Sepharose FF is used as an example system. The general rate model with steric mass-action kinetics was used; two closed-loop iex-smb network schemes were investigated (i.e., cascade and eight-zone schemes). Performance of the iex-smb schemes was examined with respect to multi-objective indicators (i.e., purity and yield) and productivity, and compared to a single column batch system with the same amount of resin utilized. A multi-objective sampling algorithm, Markov Chain Monte Carlo (mcmc), was used to generate samples for constructing Pareto optimal fronts. mcmc serves on the sampling purpose, which is interested in sampling the Pareto optimal points as well as those near Pareto optimal. Pareto fronts of the three schemes provide full information on the trade-off between the conflicting indicators, purity and yield here. The results indicate that the cascade iex-smb scheme and the integrated eight-zone iex-smb scheme have similar performance and that both outperforms the single column batch system.
536 _ _ |a 583 - Innovative Synergisms (POF3-583)
|0 G:(DE-HGF)POF3-583
|c POF3-583
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a von Lieres, Eric
|0 P:(DE-Juel1)129081
|b 1
|u fzj
700 1 _ |a Sun, Zhaoxi
|0 P:(DE-Juel1)173771
|b 2
700 1 _ |a Zhao, Liming
|0 P:(DE-HGF)0
|b 3
|e Corresponding author
773 _ _ |a 10.1016/j.compchemeng.2020.106851
|g p. 106851 -
|0 PERI:(DE-600)1499971-7
|p 106851
|t Computers & chemical engineering
|v 138
|y 2020
|x 0098-1354
856 4 _ |u https://juser.fz-juelich.de/record/875084/files/1910.05568.pdf
|y Published on 2020-04-13. Available in OpenAccess from 2022-04-13.
856 4 _ |u https://juser.fz-juelich.de/record/875084/files/1910.05568.pdf?subformat=pdfa
|x pdfa
|y Published on 2020-04-13. Available in OpenAccess from 2022-04-13.
909 C O |o oai:juser.fz-juelich.de:875084
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)129081
913 1 _ |a DE-HGF
|b Key Technologies
|l Key Technologies for the Bioeconomy
|1 G:(DE-HGF)POF3-580
|0 G:(DE-HGF)POF3-583
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-500
|4 G:(DE-HGF)POF
|v Innovative Synergisms
|x 0
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1160
|2 StatID
|b Current Contents - Engineering, Computing and Technology
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b COMPUT CHEM ENG : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 1 _ |0 I:(DE-Juel1)IBG-1-20101118
|k IBG-1
|l Biotechnologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21